BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20195281)

  • 41. HLA anchor optimization of the melan-A-HLA-A2 epitope within a long peptide is required for efficient cross-priming of human tumor-reactive T cells.
    Chauvin JM; Larrieu P; Sarrabayrouse G; Prévost-Blondel A; Lengagne R; Desfrançois J; Labarrière N; Jotereau F
    J Immunol; 2012 Mar; 188(5):2102-10. PubMed ID: 22291187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses.
    Trautmann L; Rimbert M; Echasserieau K; Saulquin X; Neveu B; Dechanet J; Cerundolo V; Bonneville M
    J Immunol; 2005 Nov; 175(9):6123-32. PubMed ID: 16237109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J; Schellens IM; van Baarle D
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A; Grünebach F; Holderried T; Appel S; Weck MM; Dörfel D; Sinzger C; Brossart P
    Mol Ther; 2006 Feb; 13(2):280-8. PubMed ID: 16219490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IFN-α boosts epitope cross-presentation by dendritic cells via modulation of proteasome activity.
    Lattanzi L; Rozera C; Marescotti D; D'Agostino G; Santodonato L; Cellini S; Belardelli F; Gavioli R; Ferrantini M
    Immunobiology; 2011 May; 216(5):537-47. PubMed ID: 21093097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects.
    Slezak SL; Bettinotti M; Selleri S; Adams S; Marincola FM; Stroncek DF
    J Transl Med; 2007 Mar; 5():17. PubMed ID: 17391521
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A CTL epitope from human cytomegalovirus IE1 defined by combining prediction of HLA binding and proteasomal processing is the target of dominant immune responses in patients after allogeneic stem cell transplantation.
    Hebart H; Rauser G; Stevanovic S; Haenle C; Nussbaum AK; Meisner C; Bissinger AL; Tenzer S; Jahn G; Loeffler J; Rammensee HG; Schild H; Einsele H
    Exp Hematol; 2003 Oct; 31(10):966-73. PubMed ID: 14550813
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting.
    Pahl-Seibert MF; Juelch M; Podlech J; Thomas D; Deegen P; Reddehase MJ; Holtappels R
    J Virol; 2005 May; 79(9):5400-13. PubMed ID: 15827154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and identification of HLA-A*1101 tetramer loading with human cytomegalovirus pp65 antigen peptide.
    Li F; Xu L; Zha Q; Chi X; Jia Q; He X
    Cell Mol Immunol; 2007 Apr; 4(2):141-6. PubMed ID: 17484809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors.
    Foster AE; Bradstock KF; Sili U; Marangolo M; Rooney CM; Gottlieb DJ
    Biol Blood Marrow Transplant; 2004 Nov; 10(11):761-71. PubMed ID: 15505607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A modified peptide stimulation method for efficient amplification of cytomegalovirus (CMV)-specific CTLs.
    Ruan GP; Ma L; Wen Q; Luo W; Zhou MQ; Wang XN
    Cell Mol Immunol; 2008 Jun; 5(3):197-201. PubMed ID: 18582401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytomegalovirus immune reconstitution occurs in recipients of allogeneic hematopoietic cell transplants irrespective of detectable cytomegalovirus infection.
    Gallez-Hawkins G; Thao L; Lacey SF; Martinez J; Li X; Franck AE; Lomeli NA; Longmate J; Diamond DJ; Spielberger R; Forman SJ; Zaia JA
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):890-902. PubMed ID: 16275592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells.
    Arrode G; Boccaccio C; Lulé J; Allart S; Moinard N; Abastado JP; Alam A; Davrinche C
    J Virol; 2000 Nov; 74(21):10018-24. PubMed ID: 11024130
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response.
    Feuchtinger T; Opherk K; Bicanic O; Schumm M; Grigoleit GU; Hamprecht K; Jahn G; Handgretinger R; Lang P
    Cytotherapy; 2010 Nov; 12(7):945-50. PubMed ID: 20230226
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype.
    Khan N; Cobbold M; Keenan R; Moss PA
    J Infect Dis; 2002 Apr; 185(8):1025-34. PubMed ID: 11930311
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
    Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
    J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion.
    Ameres S; Mautner J; Schlott F; Neuenhahn M; Busch DH; Plachter B; Moosmann A
    PLoS Pathog; 2013; 9(5):e1003383. PubMed ID: 23717207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition.
    Jouand N; Bressollette-Bodin C; Gérard N; Giral M; Guérif P; Rodallec A; Oger R; Parrot T; Allard M; Cesbron-Gautier A; Gervois N; Charreau B
    PLoS Pathog; 2018 Apr; 14(4):e1007041. PubMed ID: 29709038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-presentation of a CMV pp65 epitope by human dendritic cells using bee venom PLA2 as a membrane-binding vector.
    Babon A; Almunia C; Boccaccio C; Beaumelle B; Gelb MH; Ménez A; Maillère B; Abastado JP; Salcedo M; Gillet D
    FEBS Lett; 2005 Mar; 579(7):1658-64. PubMed ID: 15757657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells.
    Peggs K; Verfuerth S; Pizzey A; Ainsworth J; Moss P; Mackinnon S
    Blood; 2002 Jan; 99(1):213-23. PubMed ID: 11756174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.